Cargando…

Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature

Henoch-Schönlein Purpura (HSP) or IgA vasculitis is the most common systemic vasculitis of childhood and may affect skin, joints, gastrointestinal tract, and kidneys. Skin manifestations of HSP are characteristic and include a non-thrombocytopenic palpable purpura of the lower extremities and buttoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nothhaft, Matthias, Klepper, Joerg, Kneitz, Hermann, Meyer, Thomas, Hamm, Henning, Morbach, Henner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349767/
https://www.ncbi.nlm.nih.gov/pubmed/30723709
http://dx.doi.org/10.3389/fped.2018.00413
_version_ 1783390311582531584
author Nothhaft, Matthias
Klepper, Joerg
Kneitz, Hermann
Meyer, Thomas
Hamm, Henning
Morbach, Henner
author_facet Nothhaft, Matthias
Klepper, Joerg
Kneitz, Hermann
Meyer, Thomas
Hamm, Henning
Morbach, Henner
author_sort Nothhaft, Matthias
collection PubMed
description Henoch-Schönlein Purpura (HSP) or IgA vasculitis is the most common systemic vasculitis of childhood and may affect skin, joints, gastrointestinal tract, and kidneys. Skin manifestations of HSP are characteristic and include a non-thrombocytopenic palpable purpura of the lower extremities and buttocks. Rarely, HSP may initially present as or evolve into hemorrhagic vesicles and bullae. We present an otherwise healthy 5-year-old boy with an acute papulovesicular rash of both legs and intermittent abdominal pain. After a few days the skin lesions rapidly evolved into palpable purpura and hemorrhagic bullous lesions of variable size and severe hemorrhagic HSP was suspected. A histological examination of a skin biopsy showed signs of a small vessel leukocytoclastic vasculitis limited to the upper dermis and direct immunofluorescence analysis revealed IgA deposits in vessel walls, compatible with HSP. To further characterize the clinical picture and treatment options of bullous HSP we performed an extensive literature research and identified 41 additional pediatric patients with bullous HSP. Two thirds of the reported patients were treated with systemic corticosteroids, however, up to 25% of the reported patients developed skin sequelae such as hyperpigmentation and/or scarring. The early use of systemic corticosteroids has been discussed controversially and suggested in some case series to be beneficial by reducing the extent of lesions and minimizing sequelae of disease. Our patient was treated with systemic corticosteroids tapered over 5 weeks. Fading of inflammation resulted in healing of most erosions, however, a deep necrosis developing from a large blister at the dorsum of the right foot persisted so that autologous skin transplantation was performed. Re-examination 11 months after disease onset showed complete clinical remission with re-epithelialization but also scarring of some affected areas.
format Online
Article
Text
id pubmed-6349767
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63497672019-02-05 Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature Nothhaft, Matthias Klepper, Joerg Kneitz, Hermann Meyer, Thomas Hamm, Henning Morbach, Henner Front Pediatr Pediatrics Henoch-Schönlein Purpura (HSP) or IgA vasculitis is the most common systemic vasculitis of childhood and may affect skin, joints, gastrointestinal tract, and kidneys. Skin manifestations of HSP are characteristic and include a non-thrombocytopenic palpable purpura of the lower extremities and buttocks. Rarely, HSP may initially present as or evolve into hemorrhagic vesicles and bullae. We present an otherwise healthy 5-year-old boy with an acute papulovesicular rash of both legs and intermittent abdominal pain. After a few days the skin lesions rapidly evolved into palpable purpura and hemorrhagic bullous lesions of variable size and severe hemorrhagic HSP was suspected. A histological examination of a skin biopsy showed signs of a small vessel leukocytoclastic vasculitis limited to the upper dermis and direct immunofluorescence analysis revealed IgA deposits in vessel walls, compatible with HSP. To further characterize the clinical picture and treatment options of bullous HSP we performed an extensive literature research and identified 41 additional pediatric patients with bullous HSP. Two thirds of the reported patients were treated with systemic corticosteroids, however, up to 25% of the reported patients developed skin sequelae such as hyperpigmentation and/or scarring. The early use of systemic corticosteroids has been discussed controversially and suggested in some case series to be beneficial by reducing the extent of lesions and minimizing sequelae of disease. Our patient was treated with systemic corticosteroids tapered over 5 weeks. Fading of inflammation resulted in healing of most erosions, however, a deep necrosis developing from a large blister at the dorsum of the right foot persisted so that autologous skin transplantation was performed. Re-examination 11 months after disease onset showed complete clinical remission with re-epithelialization but also scarring of some affected areas. Frontiers Media S.A. 2019-01-22 /pmc/articles/PMC6349767/ /pubmed/30723709 http://dx.doi.org/10.3389/fped.2018.00413 Text en Copyright © 2019 Nothhaft, Klepper, Kneitz, Meyer, Hamm and Morbach. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Nothhaft, Matthias
Klepper, Joerg
Kneitz, Hermann
Meyer, Thomas
Hamm, Henning
Morbach, Henner
Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
title Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
title_full Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
title_fullStr Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
title_full_unstemmed Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
title_short Hemorrhagic Bullous Henoch-Schönlein Purpura: Case Report and Review of the Literature
title_sort hemorrhagic bullous henoch-schönlein purpura: case report and review of the literature
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349767/
https://www.ncbi.nlm.nih.gov/pubmed/30723709
http://dx.doi.org/10.3389/fped.2018.00413
work_keys_str_mv AT nothhaftmatthias hemorrhagicbulloushenochschonleinpurpuracasereportandreviewoftheliterature
AT klepperjoerg hemorrhagicbulloushenochschonleinpurpuracasereportandreviewoftheliterature
AT kneitzhermann hemorrhagicbulloushenochschonleinpurpuracasereportandreviewoftheliterature
AT meyerthomas hemorrhagicbulloushenochschonleinpurpuracasereportandreviewoftheliterature
AT hammhenning hemorrhagicbulloushenochschonleinpurpuracasereportandreviewoftheliterature
AT morbachhenner hemorrhagicbulloushenochschonleinpurpuracasereportandreviewoftheliterature